The Mangione family name became synonymous with violence when Luigi Mangione was arrested in December 2024 for the killing of UnitedHealthcare CEO Brian Thompson. Now, seventeen months later, his younger sister MariaSanta is beginning a fellowship at one of the nation's most competitive medical programs, and the internet is struggling to process the cognitive dissonance.
The juxtaposition is almost too neat: one sibling accused of murdering a healthcare executive, the other dedicating her life to healing. MariaSanta Mangione earned her medical degree through the conventional markers of excellence—top grades, competitive residency, now a fellowship that thousands of applicants vie for annually. By every objective measure, she has done nothing wrong. And yet her surname now carries weight that no amount of professional achievement can entirely offset.
The sins of the brother
American culture has never quite resolved its relationship with the families of those who commit notorious acts. We oscillate between extending sympathy—they did not choose their relatives—and treating proximity to infamy as a kind of contamination. The Mangione case complicates this further because Luigi became, for a certain subset of the population, something closer to a folk hero than a villain. The online discourse around MariaSanta's fellowship has split accordingly: some commenters congratulate her for persevering through what must be an impossible situation, while others question whether institutions should consider "family reputation" in their admissions decisions.
The latter position is, of course, legally and ethically indefensible. We do not punish people for crimes they did not commit. But the discomfort persists, a reminder that our stated principles and our instinctive reactions do not always align.
Medicine's quiet calculation
Medical institutions are famously risk-averse about reputation. That MariaSanta secured a prestigious fellowship suggests one of two things: either the selection committee decided her family circumstances were irrelevant to her qualifications, or they concluded that accepting her was the principled choice regardless of any potential controversy. Both possibilities reflect well on the institution, though neither will satisfy those who believe the Mangione name should carry permanent consequences.
The fellowship itself—the specific program has not been publicly identified—will place MariaSanta in close contact with patients at their most vulnerable. Some will inevitably Google their doctor and discover the connection. How they respond will say more about American attitudes toward guilt by association than about anything MariaSanta herself has done.
Our take
MariaSanta Mangione is not her brother. This should not require stating, but apparently it does. She completed medical school, matched into a competitive specialty, and is now advancing in her field—achievements that would be celebrated without hesitation if her surname were different. The instinct to scrutinize her success, to wonder whether she "deserves" it given her family's notoriety, reveals an uncomfortable truth about how quickly we abandon our principles when confronted with the visceral. She is a doctor beginning her fellowship. That is the entire story.
